Not applicableStudy completedNCT04715087What this trial is testingStaphylococcus Aureus in Atopic Dermatitis ImmunopathologyWho this might be right forAtopic Dermatitis Hospices Civils de Lyon 7
Early research (Phase 1)Study completedNCT03257644What this trial is testingA Pharmacokinetic Study of Ruxolitinib Phosphate Cream in Pediatric Subjects With Atopic DermatitisWho this might be right forAtopic Dermatitis Incyte Corporation 70
Early research (Phase 1)Study completedNCT02888704What this trial is testingSafety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic DermatitisWho this might be right forAtopic Dermatitis EHL Bio Co., Ltd. 13
Not applicableWithdrawnNCT01691209What this trial is testingEfficacy/Safety Study to Explore a New Topical Formulation in Atopic DermatitisWho this might be right forDermatitis, Atopic Bayer
Large-scale testing (Phase 3)Looking for participantsNCT07395232What this trial is testingAn Efficacy and Safety Study of DFL24498 in the Treatment of AKCWho this might be right forAtopic Keratoconjunctivitis Dompé Farmaceutici S.p.A 138
Not applicableLooking for participantsNCT05790330What this trial is testingMind and Skin - the Neurocutaneous Axis in Atopic EczemaWho this might be right forAtopic Dermatitis King's College London 90
Post-approval studies (Phase 4)UnknownNCT04520308What this trial is testingAn Open-label, Single-arm Longitudinal Study With Dupilumab for Patients With Atopic DermatitisWho this might be right forAtopic DermatitisADEczema Eric Simpson 45
Early research (Phase 1)Study completedNCT02637206What this trial is testingSkin Irritation Study of GSK2894512 CreamWho this might be right forDermatitis, Atopic GlaxoSmithKline 26
Large-scale testing (Phase 3)Study completedNCT00884585What this trial is testingEfficacy and Safety Study of Cyclosporine 0.010% to Treat Atopic KeratoconjunctivitisWho this might be right forAtopic Conjunctivitis Allergan 176
Testing effectiveness (Phase 2)Study completedNCT05375955What this trial is testingLearn About The Study Medicine (PF-07038124) In Patients With Mild To Moderate Atopic Dermatitis Or Mild To Severe Plaque Psoriasis.Who this might be right forAtopic DermatitisPlaque Psoriasis Pfizer 263
Not applicableLooking for participantsNCT07259343What this trial is testingEffect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric PopulationWho this might be right forAtopic Dermatitis (AD) Universidad Autónoma de Aguascalientes 20
Not applicableEnded earlyNCT02713035What this trial is testingBehavioral Self-Help Intervention for Pediatric Atopic Dermatitis and Eczema PatientsWho this might be right forDermatitis, AtopicEczema University of Mississippi Medical Center 10
Testing effectiveness (Phase 2)Looking for participantsNCT06524635What this trial is testingAssess Molecular Changes in Adult Participants With Moderate to Severe Hidradenitis Suppurativa or With Moderate to Severe Atopic Dermatitis Receiving Subcutaneous Injections of LutikizumabWho this might be right forHidradenitis SuppurativaAtopic Dermatitis AbbVie 60
Large-scale testing (Phase 3)Study completedNCT02755649What this trial is testingAssess the Efficacy and Safety of Dupilumab in Participants With Severe Atopic Dermatitis (AD) That Are Not Controlled With Oral Cyclosporine A (CSA) or for Those Who Cannot Take Oral CSA Because it is Not Medically AdvisableWho this might be right forAtopic Dermatitis Regeneron Pharmaceuticals 325
Large-scale testing (Phase 3)Study completedNCT03334435What this trial is testingLong-term Baricitinib (LY3009104) Therapy in Atopic DermatitisWho this might be right forAtopic Dermatitis Eli Lilly and Company 1,645
Early research (Phase 1)Not Yet RecruitingNCT07042113What this trial is testingTwo Different Formulations of 611 in Healthy Adult Subjects in ChinaWho this might be right forAtopic Dermatitis Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. 180
Testing effectiveness (Phase 2)WithdrawnNCT05240300What this trial is testingTopical BX005-A in Subjects With Moderate to Severe Atopic DermatitisWho this might be right forAtopic Dermatitis BiomX, Inc.
Post-approval studies (Phase 4)WithdrawnNCT00871208What this trial is testingTrial of Treatment of Atopic Dermatitis With Concurrent Altabax® and Topical Low-Potency Corticosteroids Versus Low-Potency Corticosteroid Mono-therapyWho this might be right forAtopic Dermatitis St. Luke's-Roosevelt Hospital Center
Not applicableStudy completedNCT02401178What this trial is testingThe Role of Filaggrin and FADS Genes on the Concentrations of PUFA Towards Its Effect on Atopic Dermatitis in InfantsWho this might be right forAtopic Dermatitis Indonesia University 400
Not applicableEnded earlyNCT03684343What this trial is testingComparative Analysis of Filmed Sequences for the Assessment of Discomfort in Atopic Dermatitis of Infants Under 6 Months of AgeWho this might be right forAtopic Dermatitis University Hospital, Brest 48